Skip to main content

FDA recall, , Moderate risk

Tandem Diabetes Care Mobi Insulin Pump

The Tandem Mobi insulin pump's Android phone app has a fault that drops the right-away part of an extended dose to zero units.

What happened

Tandem Diabetes Care, Inc. is recalling the Tandem Mobi Insulin Pump with Interoperable Technology, used with the Android Tandem Mobi Mobile app, affecting 4086 users. The recall is for a software defect in the Tandem Mobi mobile application for Android, versions 3.5.4, 3.5.2.2, and 3.5.2.1.

In these versions, the immediate portion of an extended bolus is incorrectly reduced to 0 units when the entered glucose value equals the user's active target glucose value. The later portion is still delivered, but the total insulin delivered may be less than intended.

The application does not provide a distinct alert that the immediate portion was omitted, potentially resulting in unrecognized under-delivery of insulin and hyperglycemia.

The company started the recall on its own, and users were told by e-mail. The company began the recall on October 13, 2026, and the FDA classified it on November 12, 2026. The product was distributed nationwide in the United States and in the Czech Republic.

What to do

If a code on your device is listed below:

  1. Check the lot against the recall notice and ask your provider or supplier before you stop using it.

Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.

Is yours affected?

Match the UDI-DI, catalog code and model number listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Tandem Mobi Insulin Pump with Interoperable Technology (with Android Tandem Mobi Mobile app)

    UDI-DI
    • 00389152547244
    Catalog code
    • 1015472
    Software version
    3.5.4, 3.5.2.2, 3.5.2.1
    Recall number
    Z-0437-2027
  2. Model number
    • 1015472

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

Distributed nationwide and in Czech Republic.

Recalled by
Tandem Diabetes Care, Inc.San Diego, California
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100091
Recall number
Z-0437-2027
Quantity recalled
4086 users
Recall type
Started by the company
How the company first told customers
Email

All recalls from Tandem Diabetes Care, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. Tandem Diabetes Care began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

  4. Summary updated

Summary by Recall Canary, written with AI · summary updated Nov 15, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “Tandem Diabetes Care Mobi Insulin Pump Recall.” Recall Canary. https://recallcanary.com/recall/fda/tandem-mobi-insulin-pump-with-interoperable-technology.